More articles from Therapeutic Discovery

Dual Systemic Tumor Targeting with Ligand-Directed Phage and Grp78 Promoter Induces Tumor Regression
Azadeh Kia, Justyna M. Przystal, Nastasia Nianiaris, Nicholas D. Mazarakis, Paul J. Mintz, Amin Hajitou

Molecular Cancer Therapeutics Dec 2012, 11 (12) 2566-2577; DOI: 10.1158/1535-7163.MCT-12-0587
Sorafenib-Mediated Targeting of the AAA⁺ ATPase p97/VCP Leads to Disruption of the Secretory Pathway, Endoplasmic Reticulum Stress, and Hepatocellular Cancer Cell Death
Ping Yi, Arisa Higa, Said Taouji, Mariana G. Bexiga, Esther Marza, Daniela Arma, Claire Castain, Brigitte Le Bail, Jeremy C. Simpson, Jean Rosenbaum, Charles Balabaud, Paulette Bioulac-Sage, Jean-Frédéric Blanc, Eric Chevet

Molecular Cancer Therapeutics Dec 2012, 11 (12) 2610-2620; DOI: 10.1158/1535-7163.MCT-12-0516
RSK2^Ser227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma
Yuji Shimura, Junya Kuroda, Masaki Ri, Hisao Nagoshi, Mio Yamamoto-Sugitani, Tsutomu Kobayashi, Miki Kiyota, Ryuko Nakayama, Shinsuke Mizutani, Yoshiaki Chinen, Natsumi Sakamoto, Yosuke Matsumoto, Shigeo Horiike, Yukimasa Shiotsu, Shinsuke Iida, Masafumi Taniwaki

Molecular Cancer Therapeutics Dec 2012, 11 (12) 2600-2609; DOI: 10.1158/1535-7163.MCT-12-0605
Dll4-Fc, an Inhibitor of Dll4-Notch Signaling, Suppresses Liver Metastasis of Small Cell Lung Cancer Cells through the Downregulation of the NF-κB Activity
Takuya Kuramoto, Hisatsugu Goto, Atsushi Mitsuhashi, Sho Tabata, Hirohisa Ogawa, Hisanori Uehara, Atsuro Saijo, Soji Kakiuchi, Yoichi Maekawa, Koji Yasutomo, Masaki Hanibuchi, Shin-ichi Akiyama, Saburo Sone, Yasuhiko Nishioka

Molecular Cancer Therapeutics Dec 2012, 11 (12) 2578-2587; DOI: 10.1158/1535-7163.MCT-12-0640
Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel
Diana M. Cittelly, Irina Dimitrova, Erin N. Howe, Dawn R. Cochrane, Annie Jean, Nicole S. Spoelstra, Miriam D. Post, Xian Lu, Russell R. Broaddus, Monique A. Spillman, Jennifer K. Richer

Molecular Cancer Therapeutics Dec 2012, 11 (12) 2556-2565; DOI: 10.1158/1535-7163.MCT-12-0463
Targeting Olfactomedin-like 3 Inhibits Tumor Growth by Impairing Angiogenesis and Pericyte Coverage
Marijana Miljkovic-Licina, Philippe Hammel, Sarah Garrido-Urbani, Boris P.-L. Lee, Mehdi Meguenani, Chiraz Chaabane, Marie-Luce Bochaton-Piallat, Beat A. Imhof

Molecular Cancer Therapeutics Dec 2012, 11 (12) 2588-2599; DOI: 10.1158/1535-7163.MCT-12-0245
Contrary Regulation of Bladder Cancer Cell Proliferation and Invasion by Dexamethasone-Mediated Glucocorticoid Receptor Signals
Yichun Zheng, Koji Izumi, Yi Li, Hitoshi Ishiguro, Hiroshi Miyamoto

Molecular Cancer Therapeutics Dec 2012, 11 (12) 2621-2632; DOI: 10.1158/1535-7163.MCT-12-0621
Ceramide–Antiestrogen Nanoliposomal Combinations—Novel Impact of Hormonal Therapy in Hormone-Insensitive Breast Cancer
Samy A.F. Morad, Jonathan C. Levin, Sriram S. Shanmugavelandy, Mark Kester, Gemma Fabrias, Carmen Bedia, Myles C. Cabot

Molecular Cancer Therapeutics Nov 2012, 11 (11) 2352-2361; DOI: 10.1158/1535-7163.MCT-12-0594
Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Oral Cancer
Ling Wang, Adam J. Mosel, Gregory G. Oakley, Aimin Peng

Molecular Cancer Therapeutics Nov 2012, 11 (11) 2401-2409; DOI: 10.1158/1535-7163.MCT-12-0448
Sangivamycin-like Molecule 6 Exhibits Potent Anti-Multiple Myeloma Activity through Inhibition of Cyclin-Dependent Kinase-9
Nathan G. Dolloff, Joshua E. Allen, David T. Dicker, Nicole Aqui, Dan Vogl, Jozef Malysz, Giampaolo Talamo, Wafik S. El-Deiry

Molecular Cancer Therapeutics Nov 2012, 11 (11) 2321-2330; DOI: 10.1158/1535-7163.MCT-12-0578

Main menu

User menu

Search

More articles from Therapeutic Discovery

Pages

Articles

Info for

About MCT